[Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus]
- PMID: 39397466
- PMCID: PMC11480562
- DOI: 10.19723/j.issn.1671-167X.2024.05.017
[Immunomodulatory mechanism of umbilical cord mesenchymal stem cells modified by miR-125b-5p in systemic lupus erythematosus]
Abstract
Objective: To investigate the mechanism of immunomodulatory effects of umbilical cord mesenchymal stem cells (UC-MSCs) modified by miR-125b-5p on systemic lupus erythematosus (SLE).
Methods: The expression level of miR-125b-5p was detected by real-time fluorescence quantitative PCR in UC-MSCs and peripheral blood mononuclear cells (PBMCs) from SLE patients and health checkers. Annexin V-FITC/PI apoptosis detection kit was used to detect the effect of miR-125b-5p on apoptosis of UC-MSCs. MRL/lpr mice in each group were injected with UC-MSCs via tail vein, and T-lymphocyte subsets in the spleen of the MRL/lpr mice were detected by flow cytometry after 5 weeks. The expression levels of interleukin (IL)-4 and IL-17A in serum of MRL/lpr mice were detected by ELISA. Hematoxylin-eosin staining was used to observe the pathological manifestations of the lungs and kidneys of the MRL/lpr mice.
Results: miR-125b-5p was significantly down-regulated in PBMCs of SLE patients compared with healthy controls (P < 0.01). Compared with the UC-MSCs group, the expression of miR- 125b-5p in UC-MSCs modified by miR-125b-5p group was increased (P < 0.01). The survival rate of UC-MSCs was significantly increased by miR-125b-5p (P < 0.01). Compared with the untreated group of MRL/lpr mice, the expression level of IL-4 in serum was increased (P < 0.05); the expression level of IL-17A was decreased (P < 0.05); the proportion of Th17 cells in the spleen of MRL/lpr mice was decreased (P < 0.05); the inflammatory cells infiltration and micro-thrombosis of lungs and kidneys of MRL/lpr mice were significantly reduced in the UC-MSCs modified by miR-125b-5p treatment group.
Conclusion: UC-MSCs modified by miR-125b-5p have immunomodulatory effects on systemic lupus erythematosus.
目的: 研究miR-125b-5p修饰脐带间充质干细胞(umbilical cord mesenchymal stem cells,UC-MSCs)对系统性红斑狼疮(systemic lupus erythematosus,SLE)的免疫调控作用机制。
方法: 实时荧光定量PCR检测miR-125b-5p在UC-MSCs和SLE患者、健康体检者外周血单个核细胞中的表达水平;Annexin V-FITC/PI凋亡检测试剂盒检测miR-125b-5p对UC-MSCs的凋亡影响;每周对MRL/lpr小鼠进行尾静脉注射UC-MSCs,5周后流式细胞术检测各组小鼠脾细胞T淋巴细胞亚群分化情况;ELISA法检测各组MRL/lpr小鼠血清中白细胞介素(interleukin,IL)-4和IL-17A表达水平;苏木精-伊红染色法观察MRL/lpr小鼠肺和肾组织病理变化。
结果: 与健康对照组相比,SLE患者外周血单个核细胞中miR-125b-5p的表达水平显著下调(P < 0.01);与UC-MSCs相比,miR-125b-5p转染UC-MSCs组miR-125b-5p的表达水平显著上调(P < 0.01)。miR-125b-5p转染UC-MSCs 48 h可显著提高细胞存活率(P < 0.01);与未处理的MRL/lpr小鼠组相比,miR-125b-5p修饰UC-MSCs对MRL/lpr小鼠脾脏Th17细胞分化具有明显的下调作用(P < 0.05),且在小鼠血清中IL-4表达水平明显升高(P < 0.05),IL-17A表达水平明显减低(P < 0.05)。经miR-125b-5p修饰的UC-MSCs治疗后,MRL/lpr小鼠肺和肾组织内炎性细胞浸润和微血栓减少。
结论: miR-125b-5p修饰UC-MSCs对SLE具有免疫调控作用。
Keywords: Gene modification; Immunomo-dulation; Mesenchymal stem cells; Systemic lupus erythematosus; Umbilical cord.
Conflict of interest statement
Figures






Similar articles
-
Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p/Sirt1/p53 axis.Theranostics. 2021 Jan 1;11(2):893-905. doi: 10.7150/thno.48080. eCollection 2021. Theranostics. 2021. PMID: 33391511 Free PMC article.
-
Double-Edged Effect of Hydroxychloroquine on Human Umbilical Cord-Derived Mesenchymal Stem Cells Treating Lupus Nephritis in MRL/lpr Mice.Mol Pharm. 2018 May 7;15(5):1800-1813. doi: 10.1021/acs.molpharmaceut.7b01146. Epub 2018 Apr 25. Mol Pharm. 2018. PMID: 29668284
-
MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus.Autoimmunity. 2020 Jun;53(4):201-209. doi: 10.1080/08916934.2020.1750011. Epub 2020 Apr 23. Autoimmunity. 2020. PMID: 32321315
-
Influence of mesenchymal stem cells from different origins on the therapeutic effectiveness of systemic lupus erythematosus.Exp Cell Res. 2024 Oct 1;442(2):114263. doi: 10.1016/j.yexcr.2024.114263. Epub 2024 Sep 20. Exp Cell Res. 2024. PMID: 39307406 Review.
-
Regulation of B-cell function by miRNAs impacting Systemic lupus erythematosus progression.Gene. 2025 Jan 15;933:149011. doi: 10.1016/j.gene.2024.149011. Epub 2024 Oct 18. Gene. 2025. PMID: 39427831 Review.
Cited by
-
An updated review on abnormal epigenetic modifications in the pathogenesis of systemic lupus erythematosus.Front Immunol. 2025 Jan 6;15:1501783. doi: 10.3389/fimmu.2024.1501783. eCollection 2024. Front Immunol. 2025. PMID: 39835138 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous